Key Points
-
Herpes simplex virus (HSV) undergoes a productive infection of epithelial cells at mucosal surfaces and spreads to sensory neurons, where it can undergo a latent infection. From latently infected cells, HSV can later reactivate to cause a recurrent infection in the epithelium.
-
During lytic infection, histones associate with HSV lytic genes at early times but are reduced by 4–6 hours post-infection. The histones that are associated with HSV DNA bear post-translational modifications that are markers for euchromatin or active chromatin.
-
HSV gene products, including the virion-associated protein VP16, the immediate–early infected cell protein 0 (ICP0) and the early ICP8, are required for the reduced level of histones that are associated with HSV lytic genes and the euchromatic modifications on the histones.
-
During latent infection, HSV lytic genes are associated with heterochromatin.
-
The HSV latency-associated transcript promotes the formation of heterochromatin on the HSV lytic genes and their transcriptional silencing during latent infection of sensory neurons.
-
We propose a chromatin switch model in which HSV gene products that are expressed in epithelial cells 'flip' the switch towards euchromatin in those cells, whereas gene products that are expressed in neuronal cells 'flip' the switch towards heterochromatin and silencing of lytic viral genes.
Abstract
Herpes simplex viruses (HSV) can undergo a lytic infection in epithelial cells and a latent infection in sensory neurons. During latency the virus persists until reactivation, which leads to recurrent productive infection and transmission to a new host. How does HSV undergo such different types of infection in different cell types? Recent research indicates that regulation of the assembly of chromatin on HSV DNA underlies the lytic versus latent decision of HSV. We propose a model for the decision to undergo a lytic or a latent infection in which HSV encodes gene products that modulate chromatin structure towards either euchromatin or heterochromatin, and we discuss the implications of this model for the development of therapeutics for HSV infections.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Seeger, C., Zoulim, F. & Mason, W. S. in Fields Virology 5th edn (eds Knipe, D. M. & Howley, P. M.) 2977–3029 (Lippincott, Williams & Wilkins, Philadelphia, 2007).
Pellett, P. E. & Roizman, B. in Fields Virology 5th edn (eds Knipe, D. M. & Howley, P. M.) 2479–2500 (Lippincott, Williams & Wilkins, Philadelphia, 2007).
Roizman, B., Knipe, D. M. & Whitley, R. J. in Fields Virology 5th edn (eds Knipe, D. M. & Howley, P. M.) 2501–2602 (Lippincott, Williams & Wilkins, Philadelphia, 2007).
Fisman, D. N., Lipsitch, M., Hook, E. W. & Goldie, S. J. Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States. Sex Transm. Dis. 29, 608–622 (2002).
Kimberlin, D. W. Neonatal herpes simplex infection. Clin. Microbiol. Rev. 17, 1–13 (2004).
Wald, A. & Link, K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J. Infect. Dis. 185, 45–52 (2002).
Freeman, E. E. et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20, 73–83 (2006).
Jenuwein, T. & Allis, C. D. Translating the histone code. Science 293, 1074–1080 (2001).
Margolis, T. P. et al. Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia. J. Virol. 81, 11069–11074 (2007).
Corey, L., Wald, A. & Davis, L. G. Subclinical shedding of HSV: its potential for reduction by antiviral therapy. Adv. Exp. Med. Biol. 394, 11–16 (1996).
Honess, R. W. & Roizman, B. Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides. Proc. Natl Acad. Sci. U.S.A 72, 1276–1280 (1975). This paper defined the cascade model of HSV gene regulation by showing that functional IE proteins are needed for induction of E gene expression and functional E proteins are needed for induction of L gene expression.
Wysocka, J. & Herr, W. The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. Trends Biochem. Sci. 28, 294–304 (2003).
Carrozza, M. & DeLuca, N. Interactions of the viral activator protein ICP4 with TFIID through TAF250. Mol. Cell. Biol. 16, 3085–3093 (1996).
Smith, C. A., Bates, P., Rivera-Gonzalez, R., Gu, B. & DeLuca, N. A. ICP4, the major transcriptional regulatory protein of herpes simplex virus type 1, forms a tripartite complex with TATA-binding protein and TFIIB. J. Virol. 67, 4676–4687 (1993).
Oh, J. & Fraser, N. W. Temporal association of the herpes simplex virus (HSV) genome with histone proteins during a lytic infection. J. Virol. 26 December 2007 (doi: 10.1128/JVI.00586-07).
Cohen, G. H. et al. Structural analysis of the capsid polypeptides of herpes simplex virus types 1 and 2. J. Virol. 34, 521–531 (1980).
Pignatti, P. F. & Cassai, E. Analysis of herpes simplex virus nucleoprotein complexes extracted from infected cells. J. Virol. 36, 816–828 (1980).
Cereghini, S. & Yaniv, M. Assembly of transfected DNA into chromatin: structural changes in the origin-promoter-enhancer region upon replication. EMBO J. 3, 1243–1253 (1984).
Leinbach, S. S. & Summers, W. C. The structure of herpes simplex virus type 1 DNA as probed by micrococcal nuclease digestion. J. Gen. Virol. 51, 45–59 (1980).
Lentine, A. F. & Bachenheimer, S. L. Intracellular organization of herpes simplex virus type 1 DNA assayed by staphylococcal nuclease sensitivity. Virus Res. 16, 275–292 (1990).
Monier, K., Armas, J. C., Etteldorf, S., Ghazal, P. & Sullivan, K. F. Annexation of the interchromosomal space during viral infection. Nature Cell Biol. 2, 661–665 (2000).
Simpson-Holley, M., Baines, J., Roller, R. & Knipe, D. M. Herpes simplex virus 1 UL31 and UL34 gene products promote the late maturation of viral replication compartments to the nuclear periphery. J. Virol. 78, 5591–5600 (2004).
Herrera, F. J. & Triezenberg, S. J. VP16-dependent association of chromatin-modifying coactivators and underrepresentation of histones at immediate-early gene promoters during herpes simplex virus infection. J. Virol. 78, 9689–9696 (2004). This paper was the first to show that an HSV protein caused a reduction in total chromatin and an increase in acetylated histone H3 on viral lytic gene promoters.
Kent, J. R. et al. During lytic infection herpes simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription. J. Virol. 78, 10178–10186 (2004). This paper was one of the first to show that histones with euchromatin modifications were associated with lytic genes during lytic infection.
Huang, J. et al. Trimethylation of histone H3 lysine 4 by Set1 in the lytic infection of human herpes simplex virus 1. J. Virol. 80, 5740–5746 (2006).
Everett, R. D. Transactivation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J. 3, 3135–3141 (1984).
Gelman, I. H. & Silverstein, S. Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene. Proc. Natl Acad. Sci. U.S.A. 82, 5265–5269 (1985).
O'Hare, P. & Hayward, G. S. Evidence for a direct role for both the 175,000- and 110,000-molecular-weight immediate-early proteins of herpes simplex virus in the transactivation of delayed-early promoters. J. Virol. 53, 751–760 (1985).
Quinlan, M. P. & Knipe, D. M. Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions. Mol. Cell. Biol. 5, 957–963 (1985).
Nabel, G. J., Rice, S. A., Knipe, D. M. & Baltimore, D. Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells. Science 239, 1299–1302 (1988).
Sacks, W. R. & Schaffer, P. A. Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J. Virol. 61, 829–839 (1987).
Cai, W. & Schaffer, P. A. Herpes simplex virus type 1 ICP0 regulates expression of immediate–early, early, and late genes in productively infected cells. J. Virol. 66, 2904–2915 (1992).
Stow, N. D. & Stow, E. C. Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J. Gen. Virol. 67, 2571–2585 (1986).
Chen, J. & Silverstein, S. Herpes simplex viruses with mutations in the gene encoding ICP0 are defective in gene expression. J. Virol. 66, 2916–2927 (1992).
Jordan, R. & Schaffer, P. A. Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis. J. Virol. 71, 6850–6862 (1997).
Hobbs II, W. E. & DeLuca, N. A. Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0. J. Virol. 73, 8245–8255 (1999).
Poon, A. P. W., Silverstein, S. J. & Roizman, B. An early regulatory function required in a cell type-dependent manner is expressed by the genomic but not the cDNA copy of the herpes simplex virus 1 gene encoding infected cell protein 0. J. Virol. 76, 9744–9755 (2002).
Everett, R. D. ICP0, a regulator of herpes simplex virus during lytic and latent infection. Bioessays 22, 761–770 (2000).
Everett, R. D. et al. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J. Virol. 80, 7995–8005 (2006).
Everett, R. D. et al. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J. Virol. 72, 6581–6591 (1998).
Chee, A. V., Lopez, P., Pandolfi, P. P. & Roizman, B. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J. Virol. 77, 7101–7105 (2003).
Lomonte, P. et al. Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1. J. Virol. 78, 6744–6757 (2004).
Gu, H., Liang, Y., Mandel, G. & Roizman, B. Components of the REST/CoREST/histone deacetylase repressor complex are disrupted, modified, and translocated in HSV-1-infected cells. Proc. Natl Acad. Sci. U.S.A. 102, 7571–7576 (2005).
Gu, H. & Roizman, B. Herpes simplex virus-infected cell protein 0 blocks the silencing of viral DNA by dissociating histone deacetylases from the CoREST–REST complex. Proc. Natl Acad. Sci. U.S.A. 104, 17134–17139 (2007). This paper defined a molecular mechanism by which ICP0 blocks chromatin silencing of HSV genes (by dissociating HDACs from the CoREST–REST complex).
Coleman, H. M. et al. Histone modifications associated with herpes simplex virus type 1 genomes during quiescence and following ICP0-mediated de-repression. J. Gen. Virol. 89, 68–77 (2008).
He, G., Ylisastigui, L. & Margolis, D. M. The regulation of HIV-1 gene expression: the emerging role of chromatin. DNA Cell Biol. 21, 697–705 (2002).
Poon, A. P., Gu, H. & Roizman, B. ICP0 and the US3 protein kinase of herpes simplex virus 1 independently block histone deacetylation to enable gene expression. Proc. Natl Acad. Sci. U.S.A. 103, 9993–9998 (2006).
Taylor, T. J. & Knipe, D. M. Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8. J. Virol. 78, 5856–5866 (2004).
Gao, M. & Knipe, D. M. Distal protein sequences can affect the function of a nuclear localization signal. Mol. Cell. Biol. 12, 1330–1339 (1992).
Kosz-Vnenchak, M., Coen, D. M. & Knipe, D. M. Restricted expression of herpes simplex virus lytic genes during establishment of latent infection by thymidine kinase-negative mutant viruses. J. Virol. 64, 5396–5402 (1990).
Valyi-Nagy, T., Deschmane, S. L., Dillner, A. & Fraser, N. W. Induction of cellular transcription factors in trigeminal ganglia of mice by corneal scarification, herpes simplex virus type 1 infection, and explantation of trigeminal ganglia. J. Virol. 65, 4142–4152 (1991).
Kramer, M. F., Chen, S. H., Knipe, D. M. & Coen, D. M. Accumulation of viral transcripts and DNA during establishment of latency by herpes simplex virus. J. Virol. 72, 1177–1185 (1998).
Garber, D. A., Schaffer, P. A. & Knipe, D. M. A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1. J. Virol. 71, 5885–5893 (1997). This paper provided the first evidence that the LAT causes the silencing of viral lytic genes during acute infection of sensory neurons.
Stevens, J. G., Wagner, E. K., Devi-Rao, G. B., Cook, M. L. & Feldman, L. T. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235, 1056–1059 (1987). This paper provided the first evidence of the LAT in sensory neurons.
Sedarati, F., Margolis, T. P. & Stevens, J. G. Latent infection can be established with drastically restricted transcription and replication of the HSV-1 genome. Virology 192, 687–691 (1993).
Coen, D. M. et al. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl Acad. Sci. U.S.A. 86, 4736–4740 (1989).
Speck, P. G. & Simmons, A. Divergent molecular pathways of productive and latent infection with a virulent strain of herpes simplex virus type 1. J. Virol. 65, 4001–4005 (1991).
Margolis, T. P., Sedarati, F., Dobson, A. T., Feldman, L. T. & Stevens, J. G. Pathways of viral gene expression during acute neuronal infection with HSV-1. Virology 189, 150–160 (1992).
Stevens, J. G., Haarr, L., Porter, D. D., Cook, M. L. & Wagner, E. K. Prominence of the herpes simplex virus latency-associated transcript in trigeminal ganglia from seropositive humans. J. Inf. Dis. 158, 117–123 (1988).
Krause, P. R., Croen, K. D., Straus, S. E. & Ostrove, J. M. Detection and preliminary characterization of herpes simplex virus type 1 transcripts in latently infected human trigeminal ganglia. J. Virol. 62, 4819–4823 (1988).
Rock, D. L. et al. Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J. Virol. 61, 3820–3826 (1987).
Wagner, E. K. et al. Physical characterization of the herpes simplex virus latency-associated transcript in neurons. J. Virol. 62, 1194–1202 (1988).
Farrell, M. J., Dobson, A. T. & Feldman, L. T. Herpes simplex virus latency-associated transcript is a stable intron. Proc. Natl Acad. Sci. U.S.A. 88, 790–794 (1991).
Dobson, A. T. et al. Identification of the latency-associated transcript promotor by expression of rabbit β-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus. J. Virol. 65, 3844–3851 (1989).
Lokensgard, J. R., Berthomme, H. & Feldman, L. T. The latency-associated promoter of herpes simplex virus type 1 requires a region downstream of the transcription start site for long-term expression during latency. J. Virol. 71, 6714–6719 (1997).
Lokensgard, J. R., Bloom, D. C., Dobson, A. T. & Feldman, L. T. Long-term promoter activity during herpes simplex virus latency. J. Virol. 68, 7148–7158 (1994).
Batchelor, A. H. & O'Hare, P. Regulation and cell-type-specific activity of a promoter located upstream of the latency-associated transcript of herpes simplex virus type 1. J. Virol. 64, 3269–3279 (1990).
Zwaagstra, J. C. et al. Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells: evidence for neuron specificity and for a large LAT transcript. J. Virol. 64, 5019–5028 (1990).
Kenny, J. J. et al. Identification of a second ATF/CREB-like element in the herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) promoter. Virology 200, 220–235 (1994).
Spivack, J. G. & Fraser, N. W. Detection of herpes simplex virus type 1 transcripts during latent infection in mice. J. Virol. 61, 3841–3847 (1987); erratum in 62, 663 (1988).
Godowski, P. J. & Knipe, D. M. Transcriptional control of herpesvirus gene expression: gene functions required for positive and negative regulation. Proc. Natl Acad. Sci. U.S.A. 83, 256–260 (1986).
Thomas, S. K., Gough, G., Latchman, D. S. & Coffin, R. S. Herpes simplex virus latency-associated transcript encodes a protein which greatly enhances virus growth, can compensate for deficiencies in immediate–early gene expression, and is likely to function during reactivation from virus latency. J. Virol. 73, 6618–6625 (1999).
Doerig, C., Pizer, L. I. & Wilcox, C. L. An antigen encoded by the latency-associated transcript in neuronal cell cultures latently infected with herpes simplex virus type 1. J. Virol. 65, 2724–2727 (1991).
Drolet, B. S. et al. The region of the herpes simplex virus type 1 LAT gene involved in spontaneous reactivation does not encode a functional protein. Virology 242, 221–232 (1998).
Javier, R. T., Stevens, J. G., Dissette, V. B. & Wagner, E. K. A herpes simplex virus transcript abundant in latently infected neurons is dispensable for establishment of the latent state. Virology 166, 254–257 (1988).
Leib, D. A. et al. A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J. Virol. 63, 2893–2900 (1989).
Steiner, I. et al. Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J. 8, 505–511 (1989).
Sawtell, N. M. & Thompson, R. L. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J. Virol. 66, 2150–2156 (1992).
Thompson, R. L. & Sawtell, N. M. The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. J. Virol. 71, 5432–5440 (1997).
Block, T. M. et al. An HSV LAT null mutant reactivates slowly from latent infection and makes small plaques on CV-1 monolayers. Virology 192, 618–630 (1993).
Bloom, D. C. et al. A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation. J. Virol. 70, 2449–2459 (1996).
Hill, J. M. et al. Quantitation of herpes simplex virus type 1 DNA and latency-associated transcripts in rabbit trigeminal ganglia demonstrates a stable reservoir of viral nucleic acids during latency. J. Virol. 70, 3137–3141 (1996).
Chen, S. H., Kramer, M. F., Schaffer, P. A. & Coen, D. M. A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 71, 5878–5884 (1997). This paper provided the first evidence that the LAT causes the silencing of viral lytic genes during latent infection of sensory neurons.
Mador, N., Goldenberg, D., Cohen, O., Panet, A. & Steiner, I. Herpes simplex virus type 1 latency-associated transcripts suppress viral replication and reduce immediate–early gene mRNA levels in a neuronal cell line. J. Virol. 72, 5067–5075 (1998).
Thompson, R. L. & Sawtell, N. M. Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival. J. Virol. 75, 6660–6675 (2001).
Wang, Q.-Y. et al. Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection. Proc. Natl Acad. Sci. U.S.A. 102, 16055–16059 (2005). This paper showed that the LAT promotes heterochromatin assembly on HSV lytic genes during latent infection and silencing of these genes.
Perng, G. C. et al. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 287, 1500–1503 (2000).
Bloom, D. C. HSV LAT and neuronal survival. Int. Rev. Immunol. 23, 187–198 (2004).
Fraser, J. W., Deatly, A. M., Mellerick, M. I., Muggeridge, J. I. & Spivack, J. G. in Human Herpesvirus Infections: Pathogenesis, Diagnosis, and Treatment (eds Lopez, C. & Roizman, B.) 39–54 (Raven Press, New York, 1986).
Mellerick, D. M. & Fraser, N. W. Physical state of the latent herpes simplex virus genome in a mouse model system: evidence suggesting an episomal state. Virology 158, 265–275 (1987).
Rock, D. L. & Fraser, N. W. Latent herpes simplex virus type 1 DNA contains two copies of the virion DNA joint region. J. Virol. 55, 849–852 (1985).
Rock, D. L. & Fraser, N. W. Detection of HSV-1 genome in central nervous system of latently infected mice. Nature 302, 523–525 (1983).
Deshmane, S. L. & Fraser, N. W. During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J. Virol. 63, 943–947 (1989). This paper showed that HSV DNA is associated with nucleosomes during latent infection.
Kubat, N. J., Amelio, A. L., Giordani, N. V. & Bloom, D. C. The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of LAT transcription. J. Virol. 78, 12508–12518 (2004).
Dressler, G. R., Rock, D. L. & Fraser, N. W. Latent herpes simplex virus type 1 DNA is not extensively methylated in vivo. J. Gen. Virol. 68, 1761–1765 (1987).
Kubat, N. J., Tran, R. K., McAnany, P. & Bloom, D. C. Specific histone tail modification and not DNA methylation is a determinant of herpes simplex virus type 1 latent gene expression. J. Virol. 78, 1139–1149 (2004). This paper provided evidence that the LAT promoter is associated with acetylated histones during latent infection.
Amelio, A. L., McAnany, P. K. & Bloom, D. C. A chromatin insulator-like element in the herpes simplex virus type 1 latency-associated transcript region binds CCCTC-binding factor and displays enhancer-blocking and silencing activities. J. Virol. 80, 2358–2368 (2006). This paper showed that the LAT promoter is surrounded by sequences that can function as insulators to maintain chromatin boundaries around the LAT promoter.
Spivack, J. G. & Fraser, N. W. Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection. J. Virol. 62, 1479–1485 (1988).
Amelio, A. L., Giordani, N. V., Kubat, N. J., O'Neil J. E. & Bloom, D. C. Deacetylation of the herpes simplex virus type 1 latency-associated transcript (LAT) enhancer and a decrease in LAT abundance precede an increase in ICP0 transcriptional permissiveness at early times postexplant. J. Virol. 80, 2063–2068 (2006).
Kosz-Vnenchak, M., Jacobson, J., Coen, D. M. & Knipe, D. M. Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. J. Virol. 67, 5383–5393 (1993).
Devi-Rao, G. B., Bloom, D. C., Stevens, J. G. & Wagner, E. K. Herpes simplex virus type 1 DNA replication and gene expression during explant-induced reactivation of latently infected murine sensory ganglia. J. Virol. 68, 1271–1282 (1994).
Arthur, J. L. et al. Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro. J. Virol. 75, 3885–3895 (2001).
Neumann, D. M., Bhattacharjee, P. S., Giordani, N. V., Bloom, D. C. & Hill, J. M. In vivo changes in the patterns of chromatin structure associated with the latent herpes simplex virus type 1 genome in mouse trigeminal ganglia can be detected at early times after butyrate treatment. J. Virol. 81, 13248–13253 (2007).
Kemp, L. M., Dent, C. L. & Latchman, D. S. Octamer motif mediates transcriptional repression of HSV immediate–early genes and octamer-containing cellular promoters in neuronal cells. Neuron 4, 215–222 (1990).
Lillycrop, K. A. et al. The octamer-binding protein Oct-2 represses HSV immediate–early genes in cell lines derived from latently infectable sensory neurons. Neuron 7, 381–390 (1991).
Hagmann, M., Georgiev, O., Schaffner, W. & Douville, P. Transcription factors interacting with herpes simplex virus alpha gene promoters in sensory neurons. Nucleic Acids Res. 23, 4978–4985 (1995).
Sears, A. E., Hukkanen, V., Labow, M. A., Levine, A. J. & Roizman, B. Expression of the herpes simplex virus 1 α transinducing factor (VP16) does not induce reactivation of latent virus or prevent the establishment of latency in mice. J. Virol. 65, 2929–2935 (1991).
He, X. et al. Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature 340, 35–41 (1989).
Kristie, T. M., Vogel, J. L. & Sears, A. E. Nuclear localization of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency. Proc. Natl Acad. Sci. U.S.A. 96, 1229–1233 (1999).
La Boissiere, S., Hughes, T. & O'Hare, P. HCF-dependent nuclear import of VP16. EMBO J. 18, 480–489 (1999).
Grewal, S. I. & Jia, S. Heterochromatin revisited. Nature Rev. Genet. 8, 35–46 (2007).
Kim, D. H., Villeneuve, L. M., Morris, K. V. & Rossi, J. J. Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nature Struct. Mol. Biol. 13, 793–797 (2006).
Ng, K., Pullirsch, D., Leeb, M. & Wutz, A. Xist and the order of silencing. EMBO Rep. 8, 34–39 (2007).
Rinn, J. L. et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311–1323 (2007).
Kramer, M. F. & Coen, D. M. Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 69, 1389–1399 (1995).
Chen, S.-H. et al. Neither LAT nor open reading frame P mutations increase expression of spliced or intron-containing ICP0 transcripts in mouse ganglia latently infected with herpes simplex virus. J. Virol. 76, 4764–4772 (2002).
Pfeffer, S. et al. Identification of microRNAs of the herpesvirus family. Nature Methods 2, 269–276 (2005).
Cui, C. et al. Prediction and identification of herpes simplex virus 1-encoded microRNAs. J. Virol. 80, 5499–5508 (2006).
Gupta, A., Gartner, J. J., Sethupathy, P., Hatzigeorgiou, A. G. & Fraser, N. W. Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature 442, 82–85 (2006).
Sugden, B. Virology: micro mystery solution. Nature 442, 33–34 (2006).
Lieberman, P. M. Chromatin regulation of virus infection. Trends Microbiol. 14, 132–140 (2006).
Imperiale, M. J. & Major, E. O. in Fields Virology 5th edn (eds Knipe, D. M. & Howley, P. M.) 2263–2298 (Lippincott, Williams & Wilkins, Philadelphia, 2007).
Berk, A. J. in Fields Virology 5th edn (eds Knipe, D. M. &Howley, P. M.) 2355–2394 (Lippincott, Williams &Wilkins, Philadelphia, 2007).
Saffert, R. T. & Kalejta, R. F. Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate–early gene expression. J. Virol. 80, 3863–3871 (2006).
Nevels, M., Paulus, C. & Shenk, T. Human cytomegalovirus immediate-early 1 protein facilitates viral replication by antagonizing histone deacetylation. Proc. Natl Acad. Sci. U.S.A. 101, 17234–17239 (2004).
Demonte, D., Quivy, V., Colette, Y. & Van Lint, C. Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs: implications for the development of therapeutic strategies. Biochem. Pharmacol. 68, 1231–1238 (2004).
Ylisastigui, L., Archin, N. M., Lehrman, G., Bosch, R. J. & Margolis, D. M. Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression. AIDS 18, 1101–1108 (2004).
Dudek, T. & Knipe, D. M. Replication-defective viruses as vaccines and vaccine vectors. Virology 344, 230–239 (2006).
Margolis, D. M. & Archin, N. M. Attacking HIV provirus: therapeutic strategies to disrupt persistent infection. Infect. Disord. Drug Targets 6, 369–376 (2006).
Lehrman, G. et al. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet 366, 549–555 (2005).
Feng, W. H., Hong, G., Delecluse, J. J. & Kenney, S. C. Lytic induction therapy for Epstein–Barr virus-positive B-cell lymphomas. J. Virol. 78, 1893–1902 (2004).
Feng, W. H. & Kenney, S. C. Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression. Cancer Res. 66, 8762–8769 (2006).
Neumann, D. M., Bhattacharjee, P. S. & Hill, J. M. Sodium butyrate: a chemical inducer of in vivo reactivation of herpes simplex virus type 1 in the ocular mouse model. J. Virol. 81, 6106–6110 (2007).
Acknowledgements
Studies on HSV latent infection in the authors' laboratory are supported by NIH grant P01 NS35138.
Author information
Authors and Affiliations
Corresponding author
Related links
Glossary
- Epigenetic
-
Factors that affect gene action without changing nucleotide sequence. Epigenetic modifications function by changing the structure of chromatin, and are facilitated by DNA methylation and histone modification.
- Nucleosome
-
A subunit of chromatin that is composed of DNA wrapped around a tetramer of histone proteins.
- Anterograde transport
-
The direction of anterograde axonal transport is from the cell body to the synapses. By contrast, retrograde axonal transport is from the synapses to the cell body.
- Trigeminal ganglia
-
The trigeminal ganglion is a sensory ganglion of the trigeminal nerve that occupies a cavity in the dura mater that covers the trigeminal impression near the apex of the petrous part of the temporal bone.
- Nucleoside analogues
-
Nucleoside analogues are chemically similar enough to nucleosides to be incorporated into growing DNA strands, but different enough to ensure that the resultant DNA is non-functional.
Rights and permissions
About this article
Cite this article
Knipe, D., Cliffe, A. Chromatin control of herpes simplex virus lytic and latent infection. Nat Rev Microbiol 6, 211–221 (2008). https://doi.org/10.1038/nrmicro1794
Issue Date:
DOI: https://doi.org/10.1038/nrmicro1794
This article is cited by
-
Intimate Relationship Between Stress and Human Alpha-Herpes Virus 1 (HSV-1) Reactivation from Latency
Current Clinical Microbiology Reports (2023)
-
Rasmussen’s encephalitis is characterized by relatively lower production of IFN-β and activated cytotoxic T cell upon herpes viruses infection
Journal of Neuroinflammation (2022)
-
Cohesin promotes HSV-1 lytic transcription by facilitating the binding of RNA Pol II on viral genes
Virology Journal (2021)
-
Comparative proteomics identifies Schlafen 5 (SLFN5) as a herpes simplex virus restriction factor that suppresses viral transcription
Nature Microbiology (2021)
-
Anguillid herpesvirus 1 (AngHV) ORF95 encodes a late, structural envelope protein
Virus Genes (2021)